PIRAMAL ENTERPRISES Financial Statement Analysis
|
||
The Revenues of PIRAMAL ENTERPRISES have decreased by -39.69% YoY .
The Earnings Per Share (EPS) of PIRAMAL ENTERPRISES has increased by 418.38 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
PIRAMAL ENTERPRISES Last 5 Annual Financial Results
[BOM: 500302|NSE : PEL]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Operating Income | ₹7,726 Cr | ₹12,809 Cr | ₹13,068 Cr | ₹11,883 Cr | ₹10,639 Cr |
Expenses | ₹2,014 Cr | ₹5,345 Cr | ₹6,810 Cr | ₹5,021 Cr | ₹5,484 Cr |
Operating Profit (Excl OI) | ₹5,711 Cr | ₹7,464 Cr | ₹6,258 Cr | ₹6,861 Cr | ₹5,155 Cr |
Other Income | ₹272 Cr | ₹364 Cr | ₹500 Cr | ₹314 Cr | ₹264 Cr |
Interest | ₹4,282 Cr | ₹4,209 Cr | ₹5,321 Cr | ₹4,100 Cr | ₹2,978 Cr |
Depreciation | ₹74 Cr | ₹561 Cr | ₹520 Cr | ₹401 Cr | ₹477 Cr |
Profit Before Tax | ₹2,068 Cr | ₹3,456 Cr | ₹1,407 Cr | ₹2,542 Cr | ₹1,964 Cr |
Profit After Tax | ₹1,662 Cr | ₹1,413 Cr | ₹-553 Cr | ₹1,690 Cr | ₹4,840 Cr |
Consolidated Net Profit | ₹1,923 Cr | ₹1,332 Cr | ₹24 Cr | ₹1,467 Cr | ₹5,121 Cr |
Earnings Per Share (Rs) | ₹417.71 | ₹80.58 | ₹59.07 | ₹1.07 | ₹79.54 |
PAT Margin (%) | 111.58 | 21.52 | 11.03 | -4.23 | 14.22 |
ROE(%) | 29.96 | 4.78 | 4.37 | -1.91 | 6.28 |
ROCE(%) | 11.69 | 7.73 | 10.50 | 8.63 | 8.63 |
Total Debt/Equity(x) | 1.60 | 1.56 | 1.16 | 1.38 | 2.06 |
Key Financials |
||
Market Cap | : | ₹ 18,390.6 Cr |
Revenue (TTM) | : | ₹ 9,699.7 Cr |
Net Profit(TTM) | : | ₹ -2,194.2 Cr |
EPS (TTM) | : | ₹ -97.6 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
PIRAMAL ENTERPRISES | -4.8% | -8.5% | 20.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.8% | 4% | 61.6% |
DIVIS LABORATORIES | -2.1% | -6% | 26.4% |
CIPLA | 1.5% | 3.3% | 70.6% |
DR REDDYS LABORATORIES | 0.7% | 0.4% | 44.6% |
TORRENT PHARMACEUTICALS | -4% | -2.8% | 70.3% |
ABBOTT INDIA | 6% | -3% | 39.7% |
ZYDUS LIFESCIENCES | 0.3% | 11.1% | 109.1% |
ALKEM LABORATORIES | -1.5% | -8.6% | 63.1% |
PIRAMAL ENTERPRISES Revenues
[BOM: 500302|NSE : PEL]
Y-o-Y | -39.69 % |
5 Yr CAGR | -7.69 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹7,726 Cr | -39.69 | |
Mar2022 | ₹12,809 Cr | -1.98 | |
Mar2021 | ₹13,068 Cr | 9.98 | |
Mar2020 | ₹11,883 Cr | 11.69 | |
Mar2019 | ₹10,639 Cr | - |
PIRAMAL ENTERPRISES Operating Profit
[BOM: 500302|NSE : PEL]
Y-o-Y | -23.49 % |
5 Yr CAGR | 2.59 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹5,711 Cr | -23.49 | |
Mar2022 | ₹7,464 Cr | 19.27 | |
Mar2021 | ₹6,258 Cr | -8.79 | |
Mar2020 | ₹6,861 Cr | 33.09 | |
Mar2019 | ₹5,155 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 26.87 % |
5 Yr CAGR | 11.14 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 73.93% | 26.87 | |
Mar2022 | 58.27% | 21.67 | |
Mar2021 | 47.89% | -17.06 | |
Mar2020 | 57.74% | 19.15 | |
Mar2019 | 48.46% | - |
PIRAMAL ENTERPRISES Profit After Tax
[BOM: 500302|NSE : PEL]
Y-o-Y | 44.34 % |
5 Yr CAGR | -21.72 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹1,923 Cr | 44.34 | |
Mar2022 | ₹1,332 Cr | 5,444.49 | |
Mar2021 | ₹24 Cr | -98.36 | |
Mar2020 | ₹1,467 Cr | -71.35 | |
Mar2019 | ₹5,121 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 418.49 % |
5 Yr CAGR | 67.37 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 111.58 % | 418.49 | |
Mar2022 | 21.52 % | 95.10 | |
Mar2021 | 11.03 % | Positive | |
Mar2020 | -4.23 % | Negative | |
Mar2019 | 14.22 % | - |
PIRAMAL ENTERPRISES Earnings Per Share (EPS)
[BOM: 500302|NSE : PEL]
Y-o-Y | 418.38 % |
5 Yr CAGR | 51.38 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹418 | 418.38 | |
Mar2022 | ₹81 | 36.41 | |
Mar2021 | ₹59 | 5,420.56 | |
Mar2020 | ₹1.07 | -98.65 | |
Mar2019 | ₹80 | - |
PIRAMAL ENTERPRISES Return on Capital Employed (ROCE)
[BOM: 500302|NSE : PEL]
Y-o-Y | 51.23 % |
5 Yr CAGR | 7.88 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 11.69% | 51.23 | |
Mar2022 | 7.73% | -26.38 | |
Mar2021 | 10.5% | 21.67 | |
Mar2020 | 8.63% | 0.00 | |
Mar2019 | 8.63% | - |
PIRAMAL ENTERPRISES Share Price vs Sensex
Current Share Price | : | ₹818.5 |
Current MarketCap | : | ₹ 18,390.6 Cr |
Updated EOD on | : | Mar 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL ENTERPRISES | -4.8% |
-8.5% |
20.4% |
SENSEX | -1% |
1% |
24.9% |
PIRAMAL ENTERPRISES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE FINANCE | -1.9% | -0.7% | 17.4% |
S&P BSE LARGE MIDCAP | -1.9% | -0.1% | 35.5% |
S&P BSE 500 | -2.2% | -0.9% | 36.5% |
S&P BSE ALLCAP | -2.3% | -1.4% | 38% |
S&P BSE 400 MIDSMALLCAP | -3.8% | -4.8% | 50.6% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 200 | -2% | -0.3% | 35.5% |
NIFTY 500 | -2.2% | -1% | 37.3% |
NIFTY LARGE MIDCAP 250 | -2.7% | -1.8% | 41.9% |
NIFTY500 MULTICAP 50:25:25 | -2.8% | -2.6% | 43% |
NIFTY MIDCAP150 | -3.9% | -4.1% | 51.4% |
You may also like the below Video Courses
FAQ about PIRAMAL ENTERPRISES Financials
How the annual revenues of PIRAMAL ENTERPRISES have changed ?
The Revenues of PIRAMAL ENTERPRISES have decreased by -39.69% YoY .
How the Earnings per Share (EPS) of PIRAMAL ENTERPRISES have changed?
The Earnings Per Share (EPS) of PIRAMAL ENTERPRISES has increased by 418.38 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
DR REDDYS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD vs